PRNewsWire
10 Aug 2026, 07:40 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
ADMA Biologics is facing a class action lawsuit alleging the company engaged in 'channel stuffing' to artificially simulate sales activity. — Allegations of channel stuffing suggest inflated revenue figures, which typically leads to severe loss of investor trust and potential downward price corrections.
-0.80The lawsuit claims ADMA Biologics failed to disclose a related party transaction to the market. — Undisclosed related party transactions raise red flags regarding corporate governance and financial transparency.
-0.50A securities class action lawsuit has been filed against ADMA Biologics for alleged violations of the Securities Exchange Act of 1934. — Legal proceedings create uncertainty and potential financial liability, though the merit of the claims is yet to be determined.
-0.30Continue reading
6 related stories
Top 1 mover · tap to explore
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
PRNewsWire
1h ago
